Acquired resistance to immunotherapy in MMR-D pancreatic cancer

BACKGROUND: MMR-D pancreatic cancer have been reported to respond to checkpoint inhibitor therapy. Here, we report the first case of acquired resistance to immunotherapy in MMR-D pancreatic cancer. CASE PRESENTATION: A 45-year-old woman with unresectable MMR-D pancreatic cancer was initially treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zishuo Ian, Hellmann, Matthew D., Wolchok, Jedd D., Vyas, Monika, Shia, Jinru, Stadler, Zsofia K., Diaz, Luis A., O’Reilly, Eileen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247688/
https://www.ncbi.nlm.nih.gov/pubmed/30458888
http://dx.doi.org/10.1186/s40425-018-0448-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247688/
https://www.ncbi.nlm.nih.gov/pubmed/30458888
http://dx.doi.org/10.1186/s40425-018-0448-1

Ejemplares similares